Table 3.
Artesunate transmission blocking effects according to dose and time of administration to gametocytemic mice before mosquito infection.
| Treatment (mg/kg) | Days after mouse infectiona | Hours before mosquito infection | Geom. mean Oocyst densityb [CI95%] | Percent oocyst reduction [CI95%] | Prevalence of infection % [CI95%] |
|---|---|---|---|---|---|
| Controlc | 3.5 | 10 | 120.3 [77.6-162.9] | - | 87.8 [45.1-130.5] |
| AS | 3.5 | 10 | 49.7 [34.9-64.4] | 58.7 [43.9-73.2] | 95.5 [81.4-119.7] |
| 35 mg/kg | 4 | 0.5 | 71.6 [50.6-86.1] | 43.2 [37.2-65.1] | 93.3 [75.5-111.1] |
| AS 20 mg/kg | 3.5 | 10 | 59.1 [45.0-73.3] | 50.8 [24.7-61.2] | 96.0 [80.8-110.3] |
a In P. berghei gametocytes can be morphologically distinguished on Giemsa slides on day 3 after acyclic mouse infection. Full sized, infective gametocytes appear on day 4, thus treatment on day 3 and 3.5 targets young and mature gametocytes, respectively.
b Oocyst densities (geometric mean oocysts/midgut) were considered only on oocyst positive mosquitoes.
c Control: Mice treated with 5% NaHCO3 in 0.85% normal saline.